Oxazinanes
TARGETMOL CHEMICALS INC Cefmenoxime hydrochloride
Also available in 1 mL, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. Cefmenoxime hydrochloride (Cefmenoxime hemihydrochloride) is a cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date, no severe side effects have been noted. Purity 98.41%
Medchemexpress LLC A68930 hydrochloride | 130465-39-3 | MFCD05863727 | 98.7% | 307.77 | C16H18ClNO3 | 1 ML
A68930 hydrochloride is a selective dopamine D1 receptor agonist used in research of D1 receptor pharmacology and respiratory models such as bronchiectasis. It is supplied as a solid or as a 10 mM solution in DMSO, with reported purity of approximately 98.7% and molecular weight 307.77.
- Selective dopamine D1 receptor agonist
- Available as 10 mM solution in DMSO or as solid samples
- High reported purity (~98.7%) suitable for research use
- Used in pharmacology and respiratory disease research
- Molecular formula C16H18ClNO3; molecular weight 307.77
Medchemexpress LLC Decloxizine dihydrochloride | 13073-96-6 | 99.69% | C21H30Cl2N2O2 | 100 MG
Decloxizine dihydrochloride is a histamine 1 receptor antagonist.
- H1 receptor antagonist.
Medchemexpress LLC Dihydro-β-erythroidine hydrobromide | 29734-68-7 | MFCD00153793 | >98.0% | 356.26 g·mol⁻¹ | C16H21NO3·HBr | 1 MG
Dihydro-β-erythroidine hydrobromide is a competitive antagonist of neuronal nicotinic acetylcholine receptors with preferential activity at α4-containing subtypes. It is used as a pharmacological tool in electrophysiology and behavioral studies to investigate nicotinic signaling and nicotine-related effects. Supplied as the hydrobromide salt, it is suitable for both in vitro and in vivo research applications.
- Selective, competitive antagonist of neuronal nAChRs.
- Shows selectivity for α4β2 and α4β4 receptor subtypes.
- Orally bioavailable and active in vivo.
- High purity (≥98%) suitable for research use.
- Provided as a stable hydrobromide salt for handling and formulation.
![Medchemexpress LLC 1H-Pyrrolo[2,3-b]pyridine, 2,3-dihydro- | 10592-27-5 | 959770 | 100.0% | 120.16 | 25 G](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000402770-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 1H-Pyrrolo[2,3-b]pyridine, 2,3-dihydro- | 10592-27-5 | 959770 | 100.0% | 120.16 | 25 G
2,3-Dihydro-7-azaindole (7-Azaindoline) is a biochemical reagent suitable for life science research. It can be utilized as a biological material or organic compound and is intended for research use only.
- Can be used as a biological material or organic compound
- Intended for life science related research
- Ships as a solid
- Appears white to off-white
- Storage conditions specified for solid and in solvent
Selleck Chemical LLC Cloperastine hydrochloride
Cloperastine (HT-11) is a drug with a central antitussive effect and is also endowed with an antihistaminic activity
Accela Chembio Inc 4-(4-bromophenyl)morpholine | 25g | 30483-75-1 | MFCD04112483 | 98% | Shelf Life: 1800 Days | Light Sensitive/n2
4-(4-bromophenyl)morpholine | 25g | 30483-75-1 | MFCD04112483 | 98% | Shelf Life: 1800 Days | Light Sensitive/n2
c1ccccc1 | 50mg | 525307267](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000493373.jpg-250.jpg)
eMolecules 1225376-02-2 | (R)-2-Phenylmorpholine | J & W PharmLab LLC | MFCD18249849 | 163.220 | C10H13NO | 96.000 | C1CO[C@@H](CN1)c1ccccc1 | 50mg | 525307267
(R)-2-Phenylmorpholine | J & W PharmLab LLC | 1225376-02-2 | MFCD18249849 | 163.220 | C10H13NO | 96.000 | C1CO[C@@H](CN1)c1ccccc1 | 50mg | 525307267
Chemscene ChemScene | 4-(Morpholino)phenylboronic acid | 10G | CS-W009091 | 0.98 | 186498-02-2| MFCD03095169 | 207.038
ChemScene | 4-(Morpholino)phenylboronic acid | 10G | CS-W009091 | 0.98 | 186498-02-2| MFCD03095169 | 207.038
Medchemexpress LLC 3-Amino-2-oxazolidinone (AOZ) | 80-65-9 | 98.0% | 102.09 | 10 MG
3-Amino-2-oxazolidinone (AOZ) is a metabolite of Furazolidone. It is used as an indicator for furazolidone residues in vivo and is orally active. In animal models, it has been shown to inhibit monoamine oxidase (MAO) via its metabolite in rat brain and liver, increase monoamine neurotransmitter levels (e.g., norepinephrine and dopamine) in the brain, and lower blood pressure in renal hypertensive rats.
- Used as an indicator for furazolidone residues in vivo.
- Orally active.
- Inhibits monoamine oxidase (MAO).
- Increases monoamine neurotransmitter levels in the brain.
- Lowers blood pressure in renal hypertensive rats.
![Medchemexpress LLC Mal((3S,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-glu-pab-exatecan | 3059991-66-8 | 96.1% | 1852.91 | C87H118FN9O34 | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000203287.png-250.jpg)
Medchemexpress LLC Mal((3S,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-glu-pab-exatecan | 3059991-66-8 | 96.1% | 1852.91 | C87H118FN9O34 | 50 MG
Maleimide-PEG12 β-Glu-PAB-Exatecan is a drug-linker intermediate designed for antibody-drug conjugate (ADC) synthesis. The molecule contains a maleimide functional group for thiol conjugation, a PEG12 spacer to increase hydrophilicity and spacing, and a β-glutamate PAB linkage to an exatecan payload. The material is high molecular weight and supplied as a research quantity.
- Drug-linker intermediate for ADC synthesis.
- Maleimide functional group for thiol conjugation.
- PEG12 spacer provides hydrophilicity and spacing.
- β-glu-PAB cleavable linker enables payload release.
- High molecular weight and analytical purity suitable for research use.